HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.
5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Pericardial Fluid
Pericardial Fluid
Pericardial fluid is a crucial component of the pericardium, a double-layered sac that surrounds the heart. This clear, serous fluid serves as a lubricant, facilitating smooth and frictionless movement between the layers of the pericardium during the cardiac cycle. Composed primarily of water, electrolytes, and proteins, pericardial fluid acts as a protective cushion for the heart, preventing friction-related damage and ensuring optimal cardiac function. Any imbalance in the production or absorption of pericardial fluid can lead to medical conditions such as pericardial effusion, underscoring the vital role this fluid plays in maintaining the integrity and functionality of the heart.
Committee Members
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina Heart Congress 2027 Speakers
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain